Skip to main content
. 2018 Aug 31;4(1):40–47. doi: 10.1016/j.ekir.2018.08.010

Table 3.

Immunosuppression and adjunctive treatment

Variable High-dose prednisone
n = 39
First-line CNI
n = 11
Rescue CNI
n = 16
P value
Prednisone
 Months on prednisone 13 (7–22) 8 (6–12) 24 (12–28) <0.001
 Cumulative prednisone, g 9.3 (7.5–12.5) 2.5 (1.8–3.1) 13.8 (9.2–15.8) <0.001
 Cumulative prednisone, mg/kg 134 (112–180) 36 (26–39) 177 (145–209) <0.001
 Months to taper <10 mg 7 (6–12) 6 (4–7) 11 (6–18) 0.003
Calcineurin inhibitor
 Tacrolimus 5 (45.5) 8 (50.0) 0.816
 Avg plasma level, ng/dl 5.2 (4.0–7.9) 5.8 (4.4–7.3) 0.698
 Cyclosporine 6 (54.5) 8 (50.0) 0.816
 Avg plasma level, ng/dl 134 (92–186) 128 (92–172) 0.771
 Months on CNI 12 (6–16) 16 (9–25) 0.174
Adjunctive treatment
 RAAS blockade 33 (84.6) 9 (81.8) 15 (93.8) 0.596
 Statins 21 (53.8) 5 (45.5) 10 (62.5) 0.676

Avg, average; CNI, calcineurin inhibitor; RAAS, renin−angiotensin−aldosterone system.